關於 cookie 的說明

本網站使用瀏覽器紀錄 (Cookies) 來提供您最好的使用體驗，我們使用的 Cookie 也包括了第三方 Cookie。相關資訊請訪問我們的隱私權與 Cookie 政策。如果您選擇繼續瀏覽或關閉這個提示，便表示您已接受我們的網站使用條款。

會員資訊Member Info

由PR Newswire 美通社張貼的訊息， 共 2629 篇 ，以下為 1969 - 1992 篇 訂閱此列表，掌握最新動態
Global Business News
Data Zoo Partners with Ping Identity to Power PingOne Verify with Global Authoritative Data

SYDNEY, Oct. 22, 2025 /PRNewswire/ -- Data Zoo, the trusted data layer for global identity verification, today announced its partnership with Ping Identity, a leader in securing digital identities for the world's largest enterprises. The strategic relationship provides authoritative data to PingOne Verify, offering businesses a faster, frictionless, and secure way to verify identities across global markets. Data Zoo joins a growing list of technology partners developing integrations through the Ping Identity Global Technology Partner Program. Partner solutions built on the Ping Identity Platform help organizations compete in a new digital era where user experience is increasingly important, and security cannot be sacrificed. "Our partnership with Ping Identity advances digital trust by bringing authoritative data into the PingOne Verify platform," said Jon Jones, Chief Revenue Officer at Data Zoo. "By continually expanding our global authoritative data network, we enable real-time, trusted insights that increase customer assurance and help PingOne Verify stay ahead of sophisticated identity fraud." Ping customers can now enhance identity verification through Data Zoo's global integration, providing secure access to authoritative data from more than 60 countries. As the trusted data layer for identity verification, Data Zoo continually refines its data sources to meet evolving client needs and embeds privacy and compliance into every layer, helping enterprises accurately verify customers, prevent fraud, and deliver secure onboarding at scale. "Ping Identity is committed to expanding our technology partner ecosystem to enhance digital customer experiences across the entire user journey," said Loren Russon, Senior Vice President of Product & Technology at Ping Identity. "Our collaboration with Data Zoo makes it seamless for our customers to add unique and multi-faceted data sets to the Ping Identity Platform, which provides real-time, automated verification for both individuals (KYC) and businesses (KYB). Our partnership and solution offering with Data Zoo is key to Ping Identity's vision of verified trust." About Data ZooData Zoo is the trusted data layer for global identity verification. Our single integration provides businesses with secure access to high-quality, privacy-first data from authoritative sources in over 60 countries, including registries, credit bureaus, telcos, and government databases. Through intelligent sequencing and pre-validation, Data Zoo delivers faster, more accurate verification while reducing costs and complexity. Leading enterprises and identity providers trust our data and expertise to strengthen compliance, prevent fraud, and onboard more customers globally. Data Zoo Media Contact:Emma MurphyMarketing & Communications Directoremma.murphy@datazoo.com  About Ping IdentityAt Ping, we make it possible to trust every digital moment—moments with customers, employees, partners, and non-human identities. Whether you're securing millions of users, fighting sophisticated fraud, simplifying third-party access, or embracing passwordless experiences and verifiable credentials, establishing trust shouldn't slow you down. Our enterprise-grade identity platform is built for scale, speed, and flexibility—and works seamlessly with your existing tech stack across cloud, hybrid, and on-prem. We help innovators like you accelerate growth and confidently leverage AI—making life easier for your developers, users, IT teams, and partners. With Ping, all your digital experiences start with trust. Learn more at pingidentity.com. Ping Identity Media Relationspress@pingidentity.com

文章來源 : PR Newswire 美通社 發表時間 : 瀏覽次數 : 284 加入收藏 :
大陸港澳
BTL 的 EMSCULPT NEO 用於匈牙利太空人的國際太空任務訓練

布拉格2025年10月22日 /美通社/ -- BTL 是全球醫療科技領袖，很榮幸地宣佈旗艦裝置 EMSCULPT NEO 已於具歷史意義太空飛行前太空人準備中，擔當重要角色。這作為 BTL Hungary 與 HUNOR (Hungarian To Orbit) 計劃合作的成果，EMSCULPT NEO 獲納入匈牙利研究太空人 Tibor Kapu 的密集飛行前訓練計劃中，為他即將於國際太空站 (ISS) 的任務作準備。 EMSCULPT NEO 獲納入匈牙利研究太空人 Tibor Kapu 的密集飛行前訓練計劃中，為他即將於國際太空站 (ISS) 的任務作準備。 「多個研究表示太空人在軌道上會流失高達 30% 肌肉質量，而實際情況視乎任務持續時間。EMSCULPT NEO 已成為身體調節與康復的重要部份，幫助我們盡量提升肌肉效能和恢復能力。」領導該太空人訓練團隊的匈牙利布達佩斯塞麥爾維斯大學心臟病專家兼運動醫學專家 Nóra Sydó 博士表示。 EMSCULPT NEO 是綜合調節方案的一部份，專為改善耐力、力量、平衡與恢復能力而設計。 「這項科技為我們帶來的成果超越傳統訓練。多個醫學測試顯示肌肉增大、身體組成改善，以及心肺功能增強。」 同時擔任匈牙利奧運泳隊兼多個國家級體育會隊醫的 Nóra Sydó 博士補充。 EMSCULPT NEO 是 BTL 研發，並已獲專利的肌肉刺激科技。這領先解決方案已獲數千家醫療機構使用，這些機構涵蓋多個專業，從醫學美容、功能醫學到專科醫療中心。 「這是個值得自豪的時刻。我們的使命是透過創新，改善病人生活。我們的科技在人類前往太空的路上提供支援，這進一步證明我們的裝置對社會帶來正面影響。」BTL Enterprise Group 行政總裁 Tomas Schwarz 評論。 雖然參與太空人訓練是個重要里程碑，但該裝置的好處豈止於此。「無論太空人、奧運冠軍，還是面臨肌肉流失的病人，EMSCULPT NEO 都可成為有效、安全兼非侵入性的補充解決方案，保持和增強肌肉功能。」 Nóra Sydó 博士總結，並強調在精英運動與日常病人護理中，這科技可能擔當的角色。 關於 BTL： BTL 於 1993 年成立，現時是全球醫療器械領袖，提供皮膚科、整形外科、醫療水療、骨科、關節及脊椎護理、康復、牙科、基礎醫療和婦產科等領域的創新解決方案。BTL 擁有超過 200 項專利，並聘任超過 600 名內部工程師。該公司利用科技與科學，推動醫學治療發展。該公司產品組合包括 EMSCULPT NEO®、EMFACE®、EXION®、EXOMIND™、EMSELLA® 和其他等。     聯絡方法： Daniela Rickovarickovad@btlnet.com

文章來源 : PR Newswire 美通社 發表時間 : 瀏覽次數 : 986 加入收藏 :
Global Business News
The Blood Center in New Orleans modernizes platelet processing with FDA-cleared automation from Terumo Blood and Cell Technologies

— Second U.S. site to deploy the Reveos™ system, boosting platelet supply and reducing waste LAKEWOOD, Colo., Oct. 22, 2025 /PRNewswire/ -- To help address platelet shortages and streamline blood center operations, The Blood Center in New Orleans has become the second U.S. blood center to implement the Reveos™ Automated Blood Processing System and the Lumia™ Software Platform from Terumo Blood and Cell Technologies (Terumo BCT), a medical technology company and global leader in blood management solutions. The move marks a significant step forward in transforming how blood centers process blood in the U.S. Already used globally in more than 60 countries, Reveos brings a decade of proven performance to the U.S. market. Cleared by the U.S. Food and Drug Administration (FDA) in August 2023, Reveos is the only whole blood automation system available in the U.S. that separates whole blood into platelets, plasma and red blood cells in a single fully automated centrifugation cycle. This technology enables faster processing, greater efficiency in blood component production compared to manual methods and consistently high product quality — helping blood centers meet growing demand for platelets while improving operational performance. Why whole blood automation matters Across the United States, blood centers are facing mounting challenges: platelet shortages, staffing constraints and aging donor populations are straining the system.[1,2] Nearly 98% of the U.S. platelet supply comes from apheresis donations — a process through which platelets are collected directly from a single donor using specialized equipment over a longer session.[3] Until now, apheresis has been the primary collection method to produce platelets in the U.S. Whole blood-derived platelets (WBDPs) offer a complementary solution. Instead of collecting platelets directly, blood centers collect whole blood and then separate it into its components, including platelets, after donation. Historically, this was done using manual methods that took up to 26 steps and were less efficient and more variable. Automation through Reveos has changed that. Now, WBDPs can be produced consistently and quickly, helping organizations like The Blood Center — which must collect 200 to 250 pints of blood daily to meet regional demand[4] — expand their platelet supply. "The Blood Center's adoption of Reveos marks a pivotal moment in the evolution of blood processing in the U.S.," said Chetan Makam, Senior Vice President and General Manager of Global Blood Solutions at Terumo BCT. "Their commitment to innovation and community impact reflects the very purpose of Reveos, which is to empower blood centers with automation that enhances efficiency, consistency, and responsiveness. We're proud to support their journey and excited to see the ripple effects this transformation will have across the region." A decade in the making With four devices now in routine use, The Blood Center is realizing its vision of modernized blood processing. The investment helps optimize operational efficiencies, frees up time for staff to do other tasks and enhances the process for platelet production and consistency — helping to benefit donors, hospitals and the broader community. "This is a milestone moment for our center," said Mickie Wilson-Martin, Production and Distribution Manager at The Blood Center. "We've waited a long time for a solution like this — one that truly modernizes how we manage whole blood. Being among the first in the U.S. to implement Reveos is something we're incredibly proud of, and it sends a powerful message as we work to attract younger talent. We may be small, but we are mighty, and we're here for our community." From manual to automated: A new era begins Reveos automates the balancing, centrifuging, expressing, sealing, and data transfer processes — providing efficient blood component production. The Blood Center now produces two types of platelets: apheresis and whole blood-derived, increasing overall availability and flexibility. "What surprised us most was how quickly our team saw the value — not just in time saved, but in how much more confident we feel about the consistency of every unit," said Wilson-Martin. "This is mission-critical, as the more efficient we are, the more lives we can save. We can get more blood and more consistent platelets to the hospitals and patients in our communities who depend on us." Gary Higgins, Vice President of Administrative Services at The Blood Center, emphasized the importance of consistency from a legal and operational standpoint. A former litigation lawyer, he attributes the consistently high product quality to greater peace of mind. "Coming from a background in litigation, I'm trained to ask: 'What's the worst that can happen, and how do we prevent it?'" said Higgins. "Before Reveos, ensuring every unit met regulatory standards required more manual oversight and effort. Now, we have greater peace of mind. It's reassuring to know that we're delivering a product that meets all federal and state requirements, every time." Early wins and operational impact Since implementing Reveos, The Blood Center has already seen measurable improvements, including increased platelet inventory — with up to 100 pooled platelet products manufactured per month — increasing availability for the more than 50 hospitals they serve.* Other areas seeing improvement: Reduced hands-on time, allowing staff to focus on other critical tasks and projects Improved product consistency, resulting in a more reliable platelet supply with equivalent therapeutic doses Reduced platelet waste due to lower expiration rates with a seven-day platelet shelf life "It's not just faster — it's more predictable," noted Wilson-Martin. "You gain control over your workflow, which is critical in a field where every drop counts." Impact beyond the lab The benefits of Reveos extend beyond The Blood Center to hospitals and patients across Louisiana. Faster, more efficient processing means a more agile response to routine and emergency needs. "With Reveos, we're better prepared to meet the needs of our healthcare partners," said Wilson-Martin. "We can breathe a little easier now, since we're no longer worrying about what tomorrow will look like or whether we'll have the platelets we need. It's a meaningful step forward in strengthening the blood supply infrastructure for our communities." Looking ahead This announcement is part of a broader movement toward whole blood automation in the U.S. Terumo BCT and The Blood Center will share insights from this transition in a joint abstract at the 2025 Association for the Advancement of Blood and Biotherapies (AABB) Annual Meeting in San Diego, where Billy Weales, President and CEO of The Blood Center, will speak at Terumo BCT's Science and Innovation Theater session on Monday, October 27, between 11:45 a.m. and 12:45 p.m. PT. *Data provided by The Blood Center. [1].     American Red Cross. Red Cross declares emergency blood shortage, calls for donations during National Blood Donor Month. January 7, 2024. https://www.redcross.org/about-us/news-and-events/press-release/2024/red-cross-declares-emergency-blood-shortage-calls-for-donations-during-national-blood-donor-month.html [2].     AABB. AABB24: What new data says about the state of the blood supply. October 21, 2024. https://www.aabb.org/news-resources/news/article/2024/10/21/aabb24--what-new-data-says-about-the-state-of-the-blood-supply [3].     U.S. Department of Health and Human Services, Office of Infectious Disease and HIV/AIDS Policy. (2023). National Blood Collection and Utilization Survey. Updated January 9, 2024. Accessed October 13, 2025. https://www.hhs.gov/oidp/topics/blood-tissue-safety/surveys/national-blood-collection-and-utilization-survey/index.html [4].     The Blood Center. About us. Accessed October 13, 2025. https://www.thebloodcenter.org/about-us   About the Reveos™ Automated Blood Processing System Whole blood units are collected from donors and have traditionally been separated into components — platelets, plasma and red blood cells — using manual methods that took up to 26 steps. Reveos simplifies this process and eliminates over half of the steps. The system aims to help blood centers manage staffing and improve overall efficiency by obtaining more blood products from the same number of donors. It has been used around the world for more than a decade. Reveos is expected to help U.S. blood centers meet the growing demand for platelets, which control bleeding and are used to treat patients facing trauma, cancer and other chronic conditions. Up to four units of whole blood are loaded into Reveos. The rotor spins, and the whole blood is separated into components. Plasma, platelets and red blood cells are expressed into their respective product bags, and each bag is sealed. After the procedure, the data is recorded using Terumo BCT's Lumia Software Platform, which connects with Reveos to help blood centers and processing labs achieve operational targets. Availability varies by region and country. Reveos™ is either a registered trademark or a trademark of Terumo BCT, Inc. in the United States and/or other countries. See TerumoBCT.com/Trademarks for details. About The Blood Center Founded in 1960, The Blood Center is the primary supplier of blood, blood components, and plasma derivatives to local hospitals throughout South Louisiana and parts of the Mississippi Gulf Coast. The Blood Center is a non-profit, community service organization guided by a volunteer Board of Directors, comprised of community leaders and hospital representatives. The Blood Center's mission is to provide a quality supply of blood components to meet the needs of the communities it serves, and to provide the technical support needed by the blood banking profession to achieve the highest safety and ethical standards. The Blood Center supplies over 50 hospitals and numerous outpatient transfusion facilities in Southeast Louisiana and Southern Mississippi. Many of these hospitals, including Children's Hospital in New Orleans, University Medical Center (Level I Trauma Center) and St. Tammany Parish Hospital, treat patients from throughout this region.  About Terumo BCT Terumo Blood and Cell Technologies is a medical technology company. Our products, software and services enable customers to collect and prepare blood and cells to help treat challenging diseases and conditions. Our employees worldwide believe in the potential of blood and cells to do even more for patients than they do today. This belief inspires our innovation and strengthens our collaboration with customers. Terumo Blood and Cell Technologies' customers include blood centers, hospitals, therapeutic apheresis clinics, cell collection and processing organizations, researchers and private medical practices. Our customers are based in over 160 countries across the globe. We have 750+ granted patents, with more than 150 additionally pending. We have global headquarters in Lakewood, Colorado, U.S.A., along with five regional headquarters, eight manufacturing sites and six innovation and development centers across the globe. Terumo Blood and Cell Technologies is a subsidiary of Terumo Corporation (TSE: 4543), a global leader in medical technology.   Media Contacts  Terumo Blood and Cell Technologies  Nicole Dobkin +1.720.763.5308 Nicole.Dobkin@TerumoBCT.com   Press@TerumoBCT.com    Image Box Communications Michelle Boxall +44(0)20.8943.4685 Michelle@IBcomms.agency         

文章來源 : PR Newswire 美通社 發表時間 : 瀏覽次數 : 304 加入收藏 :
Global Business News
Invitation to Electrolux Group Capital Markets Update, December 4, 2025

STOCKHOLM, Oct. 22, 2025 /PRNewswire/ -- Electrolux Group has the pleasure of inviting investors, financial analysts and business media representatives to its Capital Markets Update on December 4, 2025. The Capital Markets Update (CMU) will be held at Electrolux Group headquarters on S:t Göransgatan 143 in Stockholm, Sweden, starting at 14.00 CET on December 4, 2025, with registration from 13.30 CET. A live webcast will also be available. The agenda will include presentations by Yannick Fierling, President and CEO, and members of the Group Management team between 14.00 CET and approx. 15.30 CET. The CMU provides an opportunity for participants to get an update on Electrolux Group strategy and priorities ahead. Presentations and Q&A sessions will be followed by a brand experience tour. Please note that only presentations and Q&A sessions will be webcasted live. The CMU is planned to end at approx. 17.30 CET. Click HERE to register for the event in-person at the Electrolux Group headquarters. Click HERE to join the webcast event online. Register your participation for the event in-person no later than November 20. Please note that the number of participants attending in person is limited. More information, including the full agenda, will be made available on the registration sites further ahead. For more information, contact:Ann-Sofi Jönsson, Head of Investor Relations & Sustainability Reporting, phone +46 73 025 10 05,ann-sofi.jonsson@electrolux.comHenry Sjölin, Investor Relations Manager, phone +46 76 863 51 85, henry.sjolin@electrolux.comMaria Åkerhielm, Investor Relations Manager, phone +46 70 796 38 56, maria.akerhielm@electrolux.comMedia: Electrolux Group Press Hotline, phone +46 8 657 65 07 This information was brought to you by Cision http://news.cision.com https://news.cision.com/electrolux-group/r/invitation-to-electrolux-group-capital-markets-update--december-4--2025,c4254705 The following files are available for download: https://mb.cision.com/Main/1853/4254705/3738102.pdf Invitiation to Electrolux Capital Markets Update Dec 4  

文章來源 : PR Newswire 美通社 發表時間 : 瀏覽次數 : 292 加入收藏 :
Global Business News
Kismile Redefines Home Brewing with 3-Second Precision Heating Drip Coffee Maker

SHENZHEN, China, Oct. 22, 2025 /PRNewswire/ -- Kismile, a home appliance brand known for its thoughtful design and advanced technology, today announced the launch of its new Drip Coffee Maker, delivering café-level flavor at home with remarkable precision and simplicity. Kismile Precision Drip Coffee Maker — combining barista-level brewing precision with elegant simplicity. Built to meet the rigorous SCA and ECBC Gold Cup standards currently under certification, this model ensures every cup achieves the ideal balance of extraction, temperature, and aroma. With both hot and cold brew functions, a touch control interface, and a removable water tank, the Kismile Drip Coffee Maker caters to coffee lovers who value both performance and convenience. Professional-Grade Thick Film Heating System At the heart of the Kismile Precision Drip Coffee Maker lies an advanced thick film heating element. This technology enables water to reach the ideal extraction temperature of 197℉-205℉ in just three seconds. This rapid, precise heating is crucial for achieving the perfect "bloom" and full flavor extraction, directly meeting the strict water temperature standards set by both SCA and ECBC. Engineered for Everyday Perfection From the first drop to the final sip, every detail is crafted for consistency and comfort. The aluminum alloy body adds modern elegance and durability, while the heating system maintains precise water temperature for optimal extraction. A magnetic anti-drip design automatically stops flow when the carafe is removed—preventing spills and stains on the warming plate. The detachable water tank makes cleaning effortless and ensures each brew starts with fresh water—solving one of the most common frustrations of traditional coffee machines. Designed with Real Users in Mind "Many coffee makers on the market focus on complexity rather than daily use. We wanted to bring the joy of barista-quality coffee into a simple, intuitive design," said Cyrus Guo, Product Director at Kismile. "This coffee maker was built to address everyday frustrations—making it easier to clean, more stable in performance, and more enjoyable to use." Smart Functionality and Flexible Brewing The Kismile Drip Coffee Maker offers adjustable coffee flow and strength, allowing users to fine-tune flavor intensity according to their preference. The brewing system is compatible with V-shaped filters, flat-bottom filters, or reusable mesh filters, providing versatility for different coffee styles. Its Cold Brew Mode extracts smoothly at lower temperatures, delivering a refreshing flavor for warmer days—an exclusive feature rarely found in drip coffee makers. Meanwhile, the heat preservation system keeps coffee between 176℉-185℉ for up to 40 minutes, ensuring every cup stays warm and aromatic. For easy cleanup, both the brew funnel and glass carafe are dishwasher-safe, combining premium craftsmanship with practical everyday care. The Kismile Precision Drip Coffee Maker is now available at https://kismile.com/ and on Amazon. Performance data regarding 3-second heating to optimal extraction temperature (197℉-205℉), temperature precision, and safety features are based on internal laboratory testing under specific conditions. Actual results may vary depending on initial water temperature, ambient temperature, water quality, and altitude. All trademarks mentioned are the property of their respective owners. About Kismile Founded in 2015, Kismile is a premium home appliance brand dedicated to combining safety, innovation, and elegant design. From kitchen essentials to smart-featured appliances, Kismile products are built to make modern life simpler, warmer, and more joyful. Guided by the belief that ordinary life deserves extraordinary care, Kismile continues to innovate appliances that blend style, functionality, and love—empowering every household to savor the beauty of daily living.

文章來源 : PR Newswire 美通社 發表時間 : 瀏覽次數 : 288 加入收藏 :
Global Business News
Midea's PortaSplit air conditioner has been successfully nominated as one of TIME magazine's "Best Inventions of 2025"

BERLIN, Oct. 22, 2025 /PRNewswire/ -- Midea's PortaSplit has been named as one of TIME's "Best Inventions of 2025" — celebrating products that are changing the world. This marks the first time Midea has received this prestigious honor. PortaSplit is redefining the residential air conditioning experience with its tool free installation, offering comfort that is both simple and accessible, perfectly compatible with most European window types. Being able to enjoy the cooling performance of a split air conditioner, but not having to rely on a professional installer, was a welcome innovation for many end users, as they could either not afford a split air conditioning system or were not permitted to do so. Many Europeans sought relief during the increasingly hot summers with portable air conditioners, but by comparison, PortaSplit is more powerful, more efficient and quieter, solving previous pain points in this category. PortaSplit is also a very efficient air-to-air heat pump, meaning that end users are utilising Midea's new product, as a very cost-efficient alternative for their primary heating instead of fossil fuels or electrical heating devices. This additional feature is why PortaSplit is referred to as the first DIY-heat pump in the market. After a very successful launch in Germany, selling out for two summers in a row, PortaSplit was introduced into other European markets including France, Italy, Hungary, as well as Northern Europe and the Baltic states. Rollout will continue across Europe, bringing this solution to more households and further extending its market presence. PortaSplit is the result of in-depth local research, including home visits and surveys, leading to rapid iterative prototyping. Combining German engineering from Midea's Stuttgart based R&D Center with Italian design from the Milan Design Center, PortaSplit is a prime example for Midea's "local for local" strategy. Being named as one of the "Best Inventions of 2025" proves that Midea is on the right track with its strong focus on local research and development, with many more innovations from Europe in the pipeline.

文章來源 : PR Newswire 美通社 發表時間 : 瀏覽次數 : 262 加入收藏 :
CathWorks Announces Key Events for TCT 2025
發表時間 :
第 82 屆 EICMA 2025 向澎湃熱情致敬
發表時間 :
ROLLER Secures US$50 Million to Invest in Next-Generation Technology for Leisure and Attractions Venues
發表時間 :
SwitchBot Expands Product Portfolio with a Matter-Enabled Light Series
發表時間 :
Toward a Sustainable Development Community: Chery Group Leads the Future of Mobility Through Global ESG Action
發表時間 :
Phemex Upgrades Rewards Hub with $15,000 Package And Mystery Box System
發表時間 :
Cambrex 宣佈投資 1.2 億美元，擴大 API 製造和提升美國藥物供應彈性
發表時間 :
Visionary Holdings Launches Toronto-Based Joint Venture to Drive Global Commercialization of Innovative Stem Cell Therapy for Diabetes Remission, Targeting a $150 Billion Market Opportunity
發表時間 :
Jinxin Announces US$2 Million Share Repurchase Program
發表時間 :
踐行善舉：SM於業界論壇強調務實可持續發展理念
發表時間 :
Microban International 為了活躍與戶外生活方式，推出 EcoFresh 異味捕捉科技
發表時間 :
2025 OMODA & JAECOO International User Summit, Advancing Co-Creation and ESG Leadership
發表時間 :
MIT Technology Review's EmTech MIT 2025: Leading with Transformative Technology
發表時間 :
ILO DIRECTOR-GENERAL COMMENDS STEVEN SIM'S LEADERSHIP IN ADVANCING ASEAN'S SKILLS AGENDA AT GSF 2025
發表時間 :
ViewQwest partners with Zero Networks to deliver automated microsegmentation to enterprises across key Asian markets
發表時間 :
TDK 與 Gelion 達成全面合作協議
發表時間 :
Alps Blockchain 宣佈公司更名為 Alps
發表時間 :
Alps Blockchain Announces Corporate Rebranding to Alps
發表時間 :
2025 年 11 月 15 日 (星期六) 農曆九月廿六日
A12 藝術空間
TradeAsia 亞洲貿易網 | 開啟全球商機的專業 B2B 貿易平台 Web Builder 智慧型網站大師 | 網站建置的領導品牌
Rubber Seals, Silicone Rubber Maker | Chung Ta Rubber Solution Industrial Co., Ltd. Univer Adapter, Travel Adapter | Wonpro & Yang Ji Co., Ltd. Mini Fans, DC Blower | Risun Expanse Corp. Safety Goggles, Safety Spectacles OEM/ODM | Doris Industrial Co., Ltd. Electric Screwdriver | ASA Tools Enterprise Co. Ltd. Motorcycle Engine Cylinders, Crankshafts Manufacturer | Sheng-E MOTOR PARTS Co., Ltd. Kneader Mixer, Rubber Extruder Manufacturer | Well Shyang Machinery Co., Ltd. (WSM) TradeAsia 亞洲貿易網 | 開啟全球商機的專業 B2B 貿易平台 域名註冊 | 官網行銷第一步 打造您的專屬域名 - Asia Domain Bank 亞洲網址銀行 | AsianNet 亞洲網路 亞洲貿易展 Asian Trade Show | AsianNet 亞洲網路 Web Builder 智慧型網站大師 | 網站建置第一品牌 複成企業股份有限公司
首 頁 我的收藏 搜 尋 新聞發佈